Zoledronic Acid

Zoledronic Acid 4mg/5ml Concentrate for Solution for Infusion


​Zoledronic Acid Fresenius Kabi 4mg/5ml is a 3rd generation bisphosphonate.

ATC-Code: M05BA08

Therapeutic Indications

Zoledronic Acid Fresenius Kabi 4mg/5ml is indicated:

  • For treatment of osteolytic, osteoblastic, and mixed bone metastases of solid tumours and osteolytic lesions of multiple myeloma, in conjunction with standard antineoplastic therapy
  • Treatment of hypercalcaemia of malignancy (HCM)




Pack Size*

4mg/5 ml 10ml vials 1, 4, 10



* Not all pack sizes may be marketed or available locally.
* Product images are for illustration purposes only. 

Product Information

Please note that this product may not be available in all countries due to different registration status. Additionally, approved indications, contraindications, side effects, warnings and all other product characteristics may differ between countries.

If you require any information, please contact your local organization.